Risk of early functional decline and its association with overall survival among older adults with newly diagnosed gastrointestinal malignancies undergoing systemic therapy
Authors:
- 11 August 2025
- journal article
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 16 (7) , 102323
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Institutes of Health (K08CA234225)
This publication has 22 references indexed in Scilit:
- A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypesJournal of Cancer Survivorship, 2024
- Geriatric assessment-identified impairments and frailty in adults with cancer younger than 65: An opportunity to optimize oncology careJournal of Geriatric Oncology, 2024
- Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE)Journal of Geriatric Oncology, 2020
- Determinants of functional decline in older adults experiencing cancer (the INCAPAC study)Journal of Geriatric Oncology, 2019
- Functional decline in older patients with cancer receiving chemotherapy: A multicenter prospective studyJournal of Geriatric Oncology, 2017
- Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) scoreCancer, 2011
- Changes in functional status in older newly-diagnosed cancer patients during cancer treatment: A six-month follow-up period. Results of a prospective pilot studyJournal of Geriatric Oncology, 2011
- Understanding the Treatment Preferences of Seriously Ill PatientsNew England Journal of Medicine, 2002
- A note on quantifying follow-up in studies of failure timeControlled Clinical Trials, 1996
- THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIALBiometrika, 1934